Sinopharm Group Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sinopharm Group Co Ltd

Watchlist Manager

Watchlist

Price: 17.38 HKD -1.53% Market Closed

Market Cap: HK$54.2B

	Sinopharm Group Co Ltd HKEX:1099	CN
I	InDex Pharmaceuticals Holding AB STO:FLERIE	SE
	Royal Caribbean Cruises Ltd NYSE:RCL	US
R	Rexel SA XBER:E7V	FR
	Li Ning Co Ltd OTC:LNNGF	CN
	Liberty Latin America Ltd NASDAQ:LILA	US

Profitability Summary

Sinopharm Group Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Declining Gross Margin

8% > 7%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

4% > 3%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

2% > 1%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

2% > 2%

Low ROE

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.